Antares Pharma is a pharmaceutical company. Co. develops, manufactures and commercializes, for itself or with partners, therapeutic products using its drug delivery systems. Co.'s products include: XYOSTED® (testosterone enanthate) injection, which is its product for subcutaneous administration of testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone; and OTREXUP® (methotrexate) injection, which is a subcutaneous methotrexate injection indicated for adults with severe active rheumatoid arthritis, children with active polyarticular juvenile idiopathic arthritis and adults with severe recalcitrant psoriasis. The ATRS stock yearly return is shown above.
The yearly return on the ATRS stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2014 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the ATRS annual return calculation with any dividends reinvested as applicable (on ex-dates).
|